- Home
- HOWL vs SURG Comparison
HOWL vs SURG Comparison
Compare HOWL & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- SURG
- Stock Information
- Founded
- HOWL 2017
- SURG 2006
- Country
- HOWL United States
- SURG United States
- Employees
- HOWL N/A
- SURG N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- SURG Advertising
- Sector
- HOWL Health Care
- SURG Consumer Discretionary
- Exchange
- HOWL Nasdaq
- SURG Nasdaq
- Market Cap
- HOWL 64.5M
- SURG 56.8M
- IPO Year
- HOWL 2021
- SURG N/A
- Fundamental
- Price
- HOWL $1.22
- SURG $2.60
- Analyst Decision
- HOWL Strong Buy
- SURG Strong Buy
- Analyst Count
- HOWL 5
- SURG 1
- Target Price
- HOWL $7.20
- SURG $9.50
- AVG Volume (30 Days)
- HOWL 891.7K
- SURG 103.2K
- Earning Date
- HOWL 11-04-2025
- SURG 11-12-2025
- Dividend Yield
- HOWL N/A
- SURG N/A
- EPS Growth
- HOWL N/A
- SURG N/A
- EPS
- HOWL N/A
- SURG N/A
- Revenue
- HOWL N/A
- SURG $36,461,935.00
- Revenue This Year
- HOWL N/A
- SURG $20.20
- Revenue Next Year
- HOWL N/A
- SURG $121.54
- P/E Ratio
- HOWL N/A
- SURG N/A
- Revenue Growth
- HOWL N/A
- SURG N/A
- 52 Week Low
- HOWL $0.60
- SURG $1.05
- 52 Week High
- HOWL $2.52
- SURG $3.47
- Technical
- Relative Strength Index (RSI)
- HOWL 33.34
- SURG 43.57
- Support Level
- HOWL $1.16
- SURG $2.44
- Resistance Level
- HOWL $1.83
- SURG $2.95
- Average True Range (ATR)
- HOWL 0.14
- SURG 0.15
- MACD
- HOWL -0.06
- SURG -0.03
- Stochastic Oscillator
- HOWL 18.67
- SURG 31.51
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.